David J Light

US Patent:

20200234802, Jul 23, 2020

Filed:

Jan 17, 2020

Appl. No.:

16/745618

Inventors:

- New York NY, US
Achin Batra - Jersey City NJ, US
Alexander Padmos - New York NY, US
Angel Leung - Brooklyn NY, US
Dominic Green - Brooklyn NY, US
Zexi Chen - Forest Hills NY, US
Janet Donegan - Park City UT, US
Jessie Tseng - Brooklyn NY, US
Lauren Sutton - New York NY, US
Nathan Chan - New York NY, US
Rahul Bafna - New York NY, US
David Light - San Francisco CA, US

Assignee:

Flatiron Health, Inc. - New York NY

International Classification:

G16H 10/20
G16H 10/60
G16H 15/00

Abstract:

A graphical user interface for displaying an electronic medical record associated with a patient is provided. The graphical user interface may include an area configured to display patient information, which may include at least a name of the patient. The graphical user interface may also include an indicator displayed in association with the name of the patient. The indicator may include information specifying that the patient is potentially eligible for one or more trials, the patient is participating in one or more trials, or the patient has completed one or more trials.

US Patent:

20140279357, Sep 18, 2014

Filed:

Mar 5, 2014

Appl. No.:

14/197616

Inventors:

- Sands Point NY, US
Kenneth Tremain - Mamaroneck NY, US
David Light - New York NY, US

Assignee:

CROSSRATE TECHNOLOGIES LLC - Sands Point NY

International Classification:

G06Q 40/04

US Classification:

705 37

Abstract:

A system that analyzes toxic flow, retains the toxic flow with a dealer, and rebates all or a partial percentage of the toxic flow to liquidity providers in the market, The system allows clients and dealers can be identified by a number or code, and temporarily retains toxicity with the dealers until a predetermined amount of time and/or number of trades elapses. The dealers can then rebate back to the system any net toxicity beyond a random distribution, and the system can distribute any net toxicity beyond the random distribution to the liquidity providers. Buyers and sellers therefore receive a better price, and liquidity providers can operate with the comfort of knowing that their transactions will involve no toxicity above a random distribution.